Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 12/17/202
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
4,907,148
-
Shares change
-
+4,830,148
-
Total reported value, excl. options
-
$1,621,737
-
Value change
-
+$1,596,327
-
Number of buys
-
18
-
Price
-
$0.3300
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q4 2023
As of 31 Dec 2023 Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,907,148 shares of stock of the company.
Largest 10 holders included D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, Walleye Capital LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Bleichroeder LP, COWEN AND COMPANY, LLC, Sculptor Capital LP, and DAVIDSON KEMPNER CAPITAL MANAGEMENT LP.
This table shows 19 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.